DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc.

Biotechnology Research Two Carlson Parkway 39 employees DMAC
Employees
39
Contacts
3
Emails
3
Phones
3

DiaMedica Therapeutics Inc. Overview

Headquarters
Two Carlson Parkway
Phone Number
Available in AeroLeads
Website
diamedica.com
Industry
Biotechnology Research
Employees
39
Stock Symbol
DMAC
Funding
30.1M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), is a clinical-stage biopharmaceutical company that is focused on developing novel treatments where there is significant unmet clinical need or where no current therapies are available, with the focus on acute ischemic stroke and preeclampsia. For more information please visit www.diamedica.com.

DiaMedica Therapeutics Inc. Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
3
75.0% coverage

DiaMedica Therapeutics Inc. Org Chart

Sample employees and titles
Name Title Contact
Crystal Delvalle Clinical Trial Associate
Email Phone
Alex Aimetti Senior Biotech Executive / Scientific
View
Scott Kellen, Cpa (Inactive) Chief Financial Officer at Diamedica
Email Phone
Charles Semba (仙波), Md Chief Medical Officer and Board Member.
Email Phone

Employees by Management Level

Individual contributor 8 profiles
Executive 3 profiles
Director 3 profiles
Manager 3 profiles
Senior / Lead 2 profiles
Associate / junior 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 5 4 1
Executive 2 2 1
Finance 1 1 0

DiaMedica Therapeutics Inc. Tech Stack

Data / AI 2 profiles

Compare Similar Companies to DiaMedica Therapeutics Inc.